Briefly describe a specific question, or set of related questions, about a health care test or treatment that this program should consider.

For patients with HIV/AIDS what is the comparative effectiveness of antiviral therapy and antibacterial therapy in combination with antifungal therapy and suna therapy/Infarred therapy? Or how can they all be used together in order to decrease the growth process?

Does your question include a comparison of different health care approaches? (If no, your topic will still be considered.)

yes

If yes, explain the specific technologies, devices, drugs, or interventions you would like to see compared:

Antiviral therapy; Antibacterial therapy; Antifungal therapy and suna therapy/Infarred therapy

What patients or group(s) of patients does your question apply to? (Please include specific details such as age range, gender, coexisting diagnoses, and indications for therapy.)

Patient with HIV/Aides or any patient with Immunosupresive diseases

Are there subgroups of patients that your question might apply to? (For example, an ethnic group, stage or severity of a disease.)

Long-Term diseae process

Describe the health-related benefits you are interested in. (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

I am interested in the improvement of symptoms but the primary goal is to improve the treatment.

Describe any health-related risks, side effects, or harms that you are concerned about.

The spread of the disease

Appropriateness for EHC Program

Does your question include a health care drug, intervention, device, or technology available (or likely to be available) in the U.S.?

yes

Which priority area(s) and population(s) does this topic apply to? (check all that apply)

EHC Priority Conditions (updated in 2008)

• Cancer
• Infectious diseases, including HIV/AIDS
• Pulmonary disease/asthma

AHRQ Priority Populations

• Low income groups
• Minority groups
• Women
• Children
• Elderly
• Individuals with special health care needs, including individuals with disabilities or who need chronic care or end-of-life health care

Federal Health Care Program

• Medicaid
• Medicare
• State Children's Health Insurance Program (SCHIP)
• Other

Importance

Describe why this topic is important.

I feel that there are certain needs that really net to met regarding Immunosupressive disorders within our society.

What specifically motivated you to ask this question? (For example, you are developing a clinical guideline, working with a policy with large uncertainty about the appropriate approach, costly intervention, new research you have read, items in the media you may have seen, a clinical practice dilemma you know of, etc.)

By being a healthcare clinician I see a high rise in this area of sickness.

Does your question represent uncertainty for clinicians and/or policy-makers? (For example, variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision.)

yes

If yes, please explain:

I do feel that there is a cntroversy in what constitue the appropriate clinical care for the patients.

Potential Impact

How will an answer to your research question be used or help inform decisions for you or your group?

By educating the community.

Describe the timeframe in which an answer to your question is needed.

There have been no specific timeframe noted yet.

Describe any health disparities, inequities, or impact on vulnerable populations your question applies to.

I feel that this health care problem impacts the entire population.

Nominator Information

Other Information About You: (optional)

Please choose a description that best describes your role or perspective: (you may select more than one category if appropriate)

By educating the community.

Are you making a suggestion as an individual or on behalf of an organization?

Individual

Please tell us how you heard about the Effective Health Care Program

WEBSITE ONLINE